Ray Dalio Bridgewater Associates
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$236M |
| 2 |
CVS Health
CVS
|
+$189M |
| 3 |
Mastercard
MA
|
+$155M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$112M |
| 5 |
Meta Platforms (Facebook)
META
|
+$111M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$814M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$763M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$315M |
| 4 |
SPDR Gold Trust
GLD
|
+$140M |
| 5 |
JD.com
JD
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 25.96% |
| 2 | Healthcare | 19.03% |
| 3 | Consumer Discretionary | 12.6% |
| 4 | Financials | 7.27% |
| 5 | Communication Services | 3.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Dell
DELL
$293B
| $1.18M | 0.01% |
25,461
-76,884
| -75% | -$3.63M |
|
|
CCRN
777
DELISTED
Cross Country Healthcare
CCRN
| $1.17M | ﹤0.01% |
55,963
+6,371
| +13% | +$119K |
|
778
Trimble
TRMB
$13.9B
| $1.16M | ﹤0.01% |
19,988
-123,451
| -86% | -$8.1M |
|
779
AngioDynamics
ANGO
$649M
| $1.16M | ﹤0.01% |
59,819
+5,467
| +10% | +$112K |
|
780
Avery Dennison
AVY
$13.4B
| $1.14M | ﹤0.01% |
7,065
-30,648
| -81% | -$5.24M |
|
781
NRC Health Common Stock
NRC
$450M
| $1.14M | ﹤0.01% |
29,836
+3,813
| +15% | +$138K |
|
782
SolarEdge
SEDG
$1.95B
| $1.14M | ﹤0.01% |
4,162
-4,521
| -52% | -$1.24M |
|
|
API
783
Agora
API
$377M
| $1.13M | ﹤0.01% |
171,512
-142,848
| -45% | -$1.01M |
|
784
Outset Medical
OM
$90.8M
| $1.12M | ﹤0.01% |
5,008
+486
| +11% | +$209K |
|
785
PTC
PTC
$16B
| $1.09M | ﹤0.01% |
10,213
-41,891
| -80% | -$4.52M |
|
786
Chewy
CHWY
$9.63B
| $1.07M | ﹤0.01% |
30,812
+10,263
| +50% | +$329K |
|
787
TransUnion
TRU
$15.3B
| $1.06M | ﹤0.01% |
13,254
+2,828
| +27% | +$243K |
|
|
SRCL
788
DELISTED
Stericycle Inc
SRCL
| $1.04M | ﹤0.01% |
23,745
+8,061
| +51% | +$400K |
|
789
HubSpot
HUBS
$10.5B
| $1.02M | ﹤0.01% |
3,399
-7,804
| -70% | -$2.85M |
|
790
IDEX
IEX
$17.3B
| $997K | ﹤0.01% |
5,491
-18,937
| -78% | -$3.57M |
|
791
Entegris
ENTG
$23.2B
| $996K | ﹤0.01% |
10,816
-20,933
| -66% | -$2.27M |
|
|
DOCU
792
DocuSign
DOCU
$11.5B
| $991K | ﹤0.01% |
+17,275
| New | +$1.4M |
|
793
OrthoPediatrics
KIDS
$595M
| $980K | ﹤0.01% |
22,714
+2,783
| +14% | +$127K |
|
794
MDU Resources
MDU
$4.32B
| $969K | ﹤0.01% |
94,408
+26,681
| +39% | +$271K |
|
795
Tyler Technologies
TYL
$12.8B
| $948K | ﹤0.01% |
2,851
+572
| +25% | +$210K |
|
796
Idacorp
IDA
$8.2B
| $939K | ﹤0.01% |
8,862
+2,660
| +43% | +$287K |
|
|
CUTR
797
DELISTED
Cutera, Inc.
CUTR
| $939K | ﹤0.01% |
+25,050
| New | +$1.32M |
|
798
OGE Energy
OGE
$9.71B
| $932K | ﹤0.01% |
24,174
-17
| -0.1% | -$676 |
|
|
BHVN
799
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $919K | ﹤0.01% |
6,308
+408
| +7% | +$52.1K |
|
|
GTM
800
ZoomInfo Technologies
GTM
$1.22B
| $913K | ﹤0.01% |
27,471
+7,014
| +34% | +$309K |
|
Similar funds
Ray Dalio's Q2 2022 Portfolio in Review
As of Q2 2022, Ray Dalio held 1,084 positions worth $23.6B, down 4.9% from $24.8B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Ray Dalio deployed $1.38B of net new capital in Q2 2022, opening 116 new positions and adding to 613 existing holdings. Its largest new stake was Sea Limited: 459,240 shares worth $30.7M.
By sector, the portfolio is most concentrated in Consumer Staples at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $763M trimmed.
- Ray Dalio's largest Q2 2022 buy was Sea Limited: 459,240 shares worth $30.7M.
- Ray Dalio added most to iShares Core S&P 500 ETF in Q2 2022, an estimated $236M increase.
- Ray Dalio's biggest Q2 2022 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $763M.
- Ray Dalio fully exited Alibaba in Q2 2022, selling an estimated $814M.
- Ray Dalio's ten largest holdings make up 29% of its $23.6B portfolio in Q2 2022.
- Ray Dalio opened 116 new positions and closed 99 in Q2 2022.
- Ray Dalio's portfolio value fell 4.9% quarter-over-quarter to $23.6B.
Based on Bridgewater Associates's 13F filing for Q2 2022, filed 11 Aug 2022.